日本在线观看不卡,国产成人免费观看,国产gaysex男同视频chinese,欧美一级www

樹人論文網(wǎng)一個專業(yè)的學(xué)術(shù)咨詢網(wǎng)站!?。?/div>

CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

來源: 樹人論文網(wǎng) 瀏覽次數(shù):1090次
Bimonthly
創(chuàng)刊時間:1984
周期:Bimonthly
ISSN:0743-4863
影響因子:2.9
是否開源:No
年文章量:16
錄用比:較易
學(xué)科方向:藥學(xué)
研究方向:醫(yī)學(xué)
通訊地址:BEGELL HOUSE INC, 50 CROSS HIGHWAY, REDDING, USA, CT, 06896
官網(wǎng)地址:http://dl.begellhouse.com/journals/3667c4ae6e8fd136.html
投稿地址:http://submission.begellhouse.com/usr/login.html?prod_code=journals
網(wǎng)友分享經(jīng)驗:>12周,或約稿

CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS雜志中文介紹

該雜志邀請評論關(guān)于化學(xué)物質(zhì)與生物系統(tǒng)相互作用的原始論文。藥理學(xué)和治療學(xué)的所有方面都是適當(dāng)?shù)?,但是沒有劑量反應(yīng)或機制研究的描述性病例報告是不能接受的。只有在提供數(shù)據(jù)表明使用新方法獲得了新的或更可靠的藥理信息時,才會審查主要涉及新方法的手稿。

CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS雜志英文介紹

The Journal invites for review original papers dealing with interactions of chemicals with biological systems. All aspects of pharmacology and therapeutics are appropriate, but descriptive case reports without dose-response or mechanistic studies are not acceptable. Manuscripts dealing primarily with new methods will be reviewed only if data are presented showing that new or more reliable pharmacological information has been obtained with their use.

CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS影響因子